1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1           Hypothesis formulation:

3.2.2           Macroeconomic factor analysis:

3.2.3           Developing base number:

3.2.4           Data Triangulation:

3.2.5           Country-level data:

4.           North America Genetic Testing Services Market Landscape

4.1       PEST Analysis

5.           North America Genetic Testing Services Market – Key Market Dynamics

5.1       Market Drivers

5.1.1           Rising Prevalence of Genetic Diseases

5.1.2           Increasing Awareness and Acceptance of Personalized Medicines

5.1.3           Growing Preference for Direct-To-Consumer (DTC) Genetic Testing

5.2       Market Restraints

5.2.1           Social and Ethical Implications of Genetic Testing

5.2.2           Affordability of Genetic Services

5.3       Market Opportunities

5.3.1           Untapped Emerging Markets in Developing Countries

5.4       Future Trends

5.4.1           Artificial Intelligence-Powered Genetic Testing

5.5       Impact Analysis:

6.           Genetic Testing Services Market – North America Analysis

6.1       North America Genetic Testing Services Market Revenue (US$ Million), 2021–2031

6.2       North America Genetic Testing Services Market Forecast Analysis

7.           North America Genetic Testing Services Market Analysis – by Service Type

7.1       Predictive Testing

7.1.1           Overview

7.1.2           Predictive Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       Carrier Testing

7.2.1           Overview

7.2.2           Carrier Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.3       Prenatal Testing

7.3.1           Overview

7.3.2           Prenatal Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.4       New-born Screening

7.4.1           Overview

7.4.2           New-born Screening: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.5       Diagnostic Genetic Testing

7.5.1           Overview

7.5.2           Diagnostic Genetic Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.6       Others

7.6.1           Overview

7.6.2           Others: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           North America Genetic Testing Services Market Analysis – by Disease

8.1       Cancer

8.1.1           Overview

8.1.2           Cancer: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Cardiovascular Diseases

8.2.1           Overview

8.2.2           Cardiovascular Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3       Metabolic Diseases

8.3.1           Overview

8.3.2           Metabolic Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.4       Other Diseases

8.4.1           Overview

8.4.2           Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           North America Genetic Testing Services Market Analysis – by Service Providers

9.1       Hospital-Based Laboratories

9.1.1           Overview

9.1.2           Hospital-Based Laboratories: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2       Diagnostic Laboratories

9.2.1           Overview

9.2.2           Diagnostic Laboratories: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3       Other Service Providers

9.3.1           Overview

9.3.2           Other Service Providers: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.        North America Genetic Testing Services Market – Country Analysis

10.1     North America

10.1.1         North America Genetic Testing Services Market – Revenue and Forecast Analysis – by Country

10.1.1.1     North America Genetic Testing Services Market – Revenue and Forecast Analysis – by Country

10.1.1.2     United States: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.2.1     United States: North America Genetic Testing Services Market Share – by Service Type

10.1.1.2.2     United States: North America Genetic Testing Services Market Share – by Disease

10.1.1.2.3     United States: North America Genetic Testing Services Market Share – by Cancer Disease

10.1.1.2.4     United States: North America Genetic Testing Services Market Share – by Service Providers

10.1.1.3     Canada: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.3.1     Canada: North America Genetic Testing Services Market Share – by Service Type

10.1.1.3.2     Canada: North America Genetic Testing Services Market Share – by Disease

10.1.1.3.3     Canada: North America Genetic Testing Services Market Share – by Cancer Disease

10.1.1.3.4     Canada: North America Genetic Testing Services Market Share – by Service Providers

10.1.1.4     Mexico: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.4.1     Mexico: North America Genetic Testing Services Market Share – by Service Type

10.1.1.4.2     Mexico: North America Genetic Testing Services Market Share – by Disease

10.1.1.4.3     Mexico: North America Genetic Testing Services Market Share – by Cancer Disease

10.1.1.4.4     Mexico: North America Genetic Testing Services Market Share – by Service Providers

11.        Genetic Testing Services Market – Industry Landscape

11.1     Overview

11.2     Growth Strategies in Genetic Testing Services Market

11.3     Organic Growth Strategies

11.3.1         Overview

11.4     Inorganic Growth Strategies

11.4.1         Overview

12.        Company Profiles

12.1     Eurofins Scientific SE

12.1.1         Key Facts

12.1.2         Business Description

12.1.3         Products and Services

12.1.4         Financial Overview

12.1.5         SWOT Analysis

12.1.6         Key Developments

12.2     Exact Sciences Corp

12.2.1         Key Facts

12.2.2         Business Description

12.2.3         Products and Services

12.2.4         Financial Overview

12.2.5         SWOT Analysis

12.2.6         Key Developments

12.3     Laboratory Corp of America Holdings

12.3.1         Key Facts

12.3.2         Business Description

12.3.3         Products and Services

12.3.4         Financial Overview

12.3.5         SWOT Analysis

12.3.6         Key Developments

12.4     23andMe Holding Co

12.4.1         Key Facts

12.4.2         Business Description

12.4.3         Products and Services

12.4.4         Financial Overview

12.4.5         SWOT Analysis

12.4.6         Key Developments

12.5     Ambry Genetics Corp

12.5.1         Key Facts

12.5.2         Business Description

12.5.3         Products and Services

12.5.4         Financial Overview

12.5.5         SWOT Analysis

12.5.6         Key Developments

12.6     Quest Diagnostics Inc

12.6.1         Key Facts

12.6.2         Business Description

12.6.3         Products and Services

12.6.4         Financial Overview

12.6.5         SWOT Analysis

12.6.6         Key Developments

12.7     Illumina Inc

12.7.1         Key Facts

12.7.2         Business Description

12.7.3         Products and Services

12.7.4         Financial Overview

12.7.5         SWOT Analysis

12.7.6         Key Developments

12.8     F. Hoffmann-La Roche Ltd

12.8.1         Key Facts

12.8.2         Business Description

12.8.3         Products and Services

12.8.4         Financial Overview

12.8.5         SWOT Analysis

12.8.6         Key Developments

12.9     NeoGenomics Inc

12.9.1         Key Facts

12.9.2         Business Description

12.9.3         Products and Services

12.9.4         Financial Overview

12.9.5         SWOT Analysis

12.9.6         Key Developments

12.10  Centogene NV

12.10.1      Key Facts

12.10.2      Business Description

12.10.3      Products and Services

12.10.4      Financial Overview

12.10.5      SWOT Analysis

12.10.6      Key Developments

12.11  Ancestry Genomics Inc

12.11.1      Key Facts

12.11.2      Business Description

12.11.3      Products and Services

12.11.4      Financial Overview

12.11.5      SWOT Analysis

12.11.6      Key Developments

12.12  Gene By Gene Ltd

12.12.1      Key Facts

12.12.2      Business Description

12.12.3      Products and Services

12.12.4      Financial Overview

12.12.5      SWOT Analysis

12.12.6      Key Developments

12.13  SIVOTEC BioInformatics LLC

12.13.1      Key Facts

12.13.2      Business Description

12.13.3      Products and Services

12.13.4      Financial Overview

12.13.5      SWOT Analysis

12.13.6      Key Developments

12.14  Progenesis

12.14.1      Key Facts

12.14.2      Business Description

12.14.3      Products and Services

12.14.4      Financial Overview

12.14.5      SWOT Analysis

12.14.6      Key Developments

12.15  Fulgent Genetics, Inc

12.15.1      Key Facts

12.15.2      Business Description

12.15.3      Products and Services

12.15.4      Financial Overview

12.15.5      SWOT Analysis

12.15.6      Key Developments

12.16  VERITAS INTERCONTINENTAL

12.16.1      Business Description

12.16.2      Products and Services

12.16.3      Financial Overview

12.16.4      SWOT Analysis

12.16.5      Key Developments

12.17  GeneDx, LLC

12.17.1      Key Facts

12.17.2      Business Description

12.17.3      Products and Services

12.17.4      Financial Overview

12.17.5      SWOT Analysis

12.17.6      Key Developments

13.        Appendix

13.1     About The Insight Partners

13.2     Glossary of Terms

List of Tables

Table 1.             North America Genetic Testing Services Market Segmentation

Table 2.             North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3.             North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Type

Table 4.             North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease

Table 5.             North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Service Providers

Table 6.             North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 7.             United States: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type

Table 8.             United States: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease

Table 9.             United States: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease

Table 10.          United States: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers

Table 11.          Canada: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type

Table 12.          Canada: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease

Table 13.          Canada: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease

Table 14.          Canada: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers

Table 15.          Mexico: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Type

Table 16.          Mexico: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease

Table 17.          Mexico: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Cancer Disease

Table 18.          Mexico: North America Genetic Testing Services Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Service Providers

Table 19.          Recent Organic Growth Strategies in Genetic Testing Services Market

Table 20.          Recent Inorganic Growth Strategies in the Genetic Testing Services Market

Table 21.          Glossary of Terms, Genetic Testing Services Market

List of Figures

Figure 1.           North America Genetic Testing Services Market Segmentation – Country

Figure 2.           PEST Analysis

Figure 3.           North America Genetic Testing Services Market – Key Market Dynamics

Figure 4.           Impact Analysis of Drivers and Restraints

Figure 5.           North America Genetic Testing Services Market Revenue (US$ Million), 2021–2031

Figure 6.           North America Genetic Testing Services Market Share (%) – by Service Type (2023 and 2031)

Figure 7.           Predictive Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           carrier testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9.           Prenatal Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 10.        New-born Screening: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Diagnostic Genetic Testing: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        Others: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13.        North America Genetic Testing Services Market Share (%) – by Disease (2023 and 2031)

Figure 14.        Cancer: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15.        Cardiovascular Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        Metabolic Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17.        Other Diseases: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18.        North America Genetic Testing Services Market Share (%) – by Service Providers (2023 and 2031)

Figure 19.        Hospital-Based Laboratories: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20.        Diagnostic Laboratories: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 21.        Other Service Providers: North America Genetic Testing Services Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 22.        North America Genetic Testing Services Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23.        United States: North America Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 24.        Canada: North America Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 25.        Mexico: North America Genetic Testing Services Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 26.        Growth Strategies in Genetic Testing Services Market